查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014450

DNA和RNA样品製备市场：按产品类型、技术、应用和最终用户分類的全球市场预测—2026-2032年

DNA-RNA Sample Preparation Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，DNA 和 RNA 样品製备市场价值将达到 24.2 亿美元，到 2026 年将成长到 26.3 亿美元，到 2032 年将达到 45.6 亿美元，复合年增长率为 9.49%。

主要市场统计数据
基准年 2025 24.2亿美元
预计年份：2026年 26.3亿美元
预测年份 2032 45.6亿美元
复合年增长率 (%) 9.49%

这本权威的入门书籍说明了DNA 和 RNA 样本製备如何支撑现代生命科学工作流程中的实验室可靠性、提高通量和符合监管要求。

DNA和RNA样本製备是现代生命科学工作流程的基础，对诊断、治疗方法开发和基础研究的成果至关重要。实验室面临越来越大的压力，需要在控製成本和满足监管要求的同时，实现更高的通量、更好的重复性和可追溯的监管链。因此，样本製备已从简单的常规实验步骤演变为影响定序、分子诊断和生物标记发现等下游流程成功与否的关键因素。

自动化、试剂化学的进步、检测的去中心化以及数位化工作流程的整合正在改变世界各地实验室的核酸样本製备方法。

技术创新、操作需求和不断变化的法规共同作用，正在重塑样本製备流程，并改变实验室处理核酸的方式。自动化不再是仅限于高通量中心的专属功能，而是各机构寻求降低变异性、提高处理能力并将技术人员重新分配到更高价值任务的策略重点。自动化工作站和整合平台简化了从提取到样品製备的工作流程，从而为定序和诊断检测提供更一致的输入材料。

该评估旨在评估美国关税政策和贸易趋势的变化如何影响样品製备业务的采购韧性、供应商策略和业务连续性。

美国关税政策和贸易措施日益凸显了整个生命科学生态系统对具有韧性的供应链和弹性筹资策略的需求。关税结构的变化会影响仪器、试剂盒和试剂的采购成本，并影响库存策略、供应商多元化和本地製造伙伴关係等方面的决策。对于依赖及时交货和检验样本的实验室而言，关税引发的成本转移可能会扰乱采购週期，并迫使其重新谈判供应商合约。

详细的细分洞察揭示了仪器、试剂盒和试剂的化学特性、核心技术、多样化的应用以及不同的最终用户如何决定不同的采购和验证优先事项。

对产品细分的详细分析阐明了效能提升与采购复杂性之间的交集。产品类型包括仪器、试剂盒和试剂。仪器包括自动化工作站和离心机，它们在处理能力、面积和整合潜力方面差异显着。试剂盒包括样品製备盒和核酸萃取试剂盒，其中样品製备盒可进一步细分为DNA文库建构试剂盒和RNA文库建构试剂盒，二者对酵素处理和操作的要求各不相同。试剂包括缓衝液和酶，它们各自具有独特的化学性质，这些性质决定了产量、完整性以及与下游检测的兼容性。了解这些差异对于根据工作流程目标和验证限制客製化采购至关重要。

美洲、欧洲、中东和非洲以及亚太地区的地理差异如何决定样品製备解决方案的采购重点、验证需求和区域市场进入策略。

区域趋势在塑造供应链、监管预期以及样本製备技术的普及率方面发挥决定性作用。在美洲，先进的临床检查室和研究机构的集中，以及强大的生物技术产业，正在推动对高通量自动化和经验证试剂盒的需求。同时，筹资策略强调与伙伴关係建立伙伴关係并遵守区域监管要求。此外，美洲正在积极投资本地生产和分销网络，以支援快速部署并应对关税和物流方面的复杂性。

竞争格局分析表明，平台整合、化学差异化、本地支援和策略伙伴关係关係如何决定供应商的优势和客户的偏好。

DNA和RNA样本製备生态系统的竞争动态是由成熟的仪器製造商、专业的试剂供应商和敏捷的试剂盒开发商共同塑造的。领导企业专注于平台整合、自动化功能和软体驱动的工作流程管理，而试剂和试剂盒供应商则透过化学创新、易用性和针对特定应用（例如临床诊断和法医学分析）的验证支援来脱颖而出。仪器和耗材供应商之间的策略合作和共同开发契约日益普遍，从而打造出能够简化验证并加速部署的捆绑式解决方案。

为供应商和检查室管理人员提供切实可行的策略建议，以增强韧性、简化验证流程并加速采用先进的样品製备解决方案。

产业领导者应优先考虑能够增强营运韧性、促进技术互通性并降低终端用户验证门槛的策略。首先，投资于支援多种萃取和样品製备化学反应的模组化自动化平台，可以让客户在无需完全更换硬体的情况下调整工作流程，从而保护现有部署并降低采购门槛。这种模组化设计应辅以开放介面和软体API，以简化与实验室资讯系统和分析流程的整合。

高度透明且严格三角验证的调查方法，结合访谈、技术评估、文献回顾和比较评估，确保了实用可靠的见解。

本分析整合了第一手和第二手调查、技术文献以及相关人员访谈，旨在建构对DNA和RNA样本製备实际情况的实证理解。主要资讯来源包括对临床、法医学和研究领域的检查室管理人员、采购负责人和产品专家的结构化访谈，以及对典型工作流程中仪器性能和试剂稳定性的技术评估。这些访谈资料辅以对同侪审查文献和监管指南的全面审查，以确保与当前的最佳实践和合规要求保持一致。

摘要强调了稳健、互通性和检验的样本製备技术对于支持可靠的基因组分析和诊断结果的战略重要性。

简而言之，DNA和RNA样本製备不再只是一项检查室工作，而是一个策略性领域，它对下游基因组分析和诊断流程的品质、速度和成本效益有显着影响。自动化和试剂化学领域的技术进步不断拓展着相关能力，同时也提高了人们对供应连续性、检验支援以及与数位化检查室生态系统整合的期望。因此，供应商和最终用户都必须采取全面的观点，优先考虑互通性、可追溯性和可靠性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：DNA/RNA样品製备市场：依产品类型划分

  • 装置
    • 自动化工作站
    • 离心机
  • 成套工具
    • 样品製备工具包
      • DNA文库建构试剂盒
      • RNA文库建构试剂盒
    • 核酸萃取试剂盒
  • 试剂
    • 缓衝
    • 酵素

第九章：DNA/RNA样品製备市场：依技术划分

  • 列式法
  • 磁选
  • 降水法

第十章：DNA/RNA样品製备市场：依应用领域划分

  • 临床诊断
    • 基因检测
    • 感染疾病
  • 法医学
    • DNA指纹图谱
    • RNA分析
  • 研究
    • 基因组学
    • 转录组学

第十一章 DNA/RNA 样本製备市场：依最终用户划分

  • 学术机构
    • 研究机构
    • 大学
  • 生技公司
    • 生物製药公司
    • 生技Start-Ups
  • 医院
    • 临床检查室
    • 诊断中心
  • 製药公司
    • 大型製药企业
    • 学名药公司

第十二章：DNA/RNA样品製备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：DNA/RNA样品製备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 DNA/RNA 样本製备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国DNA/RNA样本製备市场

第十六章：中国DNA与RNA样本製备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Akonni Biosystems, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Norgen Biotek Corp.
  • Omega Bio-tek, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Sage Science, Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4348D129FA47

The DNA-RNA Sample Preparation Market was valued at USD 2.42 billion in 2025 and is projected to grow to USD 2.63 billion in 2026, with a CAGR of 9.49%, reaching USD 4.56 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.42 billion
Estimated Year [2026] USD 2.63 billion
Forecast Year [2032] USD 4.56 billion
CAGR (%) 9.49%

An authoritative primer on how DNA and RNA sample preparation now underpins laboratory reliability, throughput scaling, and regulatory compliance across modern life science workflows

The preparation of DNA and RNA samples is foundational to modern life sciences workflows, driving outcomes in diagnostics, therapeutics development, and basic research. Laboratories are increasingly pressured to deliver higher throughput, greater reproducibility, and traceable chain-of-custody while managing cost and regulatory requirements. As a result, sample preparation has evolved from a routine laboratory step into a critical enabler of downstream success for sequencing, molecular diagnostics, and biomarker discovery.

Across clinical and research settings, the demand for streamlined procedures and automation has intensified. Technological advances in enzymology, buffer chemistry, and extraction hardware have reduced hands-on time and variability, yet they have also introduced new considerations around compatibility, validation, and operator training. In parallel, regulatory scrutiny and quality management expectations are extending into pre-analytical stages, prompting procurement and operations teams to rethink vendor selection, validation protocols, and supply continuity.

This introduction frames the subsequent analysis by highlighting the operational and strategic levers available to laboratory leaders. It underscores the interplay between instrumentation, consumable design, and workflow integration, and points to the need for a nuanced evaluation that balances performance, total cost of ownership, and future-proofing against technological shifts. The following sections expand on these themes, offering insight into the transformative forces reshaping sample preparation and practical implications for decision-makers.

How automation, reagent chemistry advances, decentralization of testing, and digital workflow integration are collectively transforming nucleic acid sample preparation practices in laboratories worldwide

Sample preparation is being reshaped by a convergence of technological innovation, operational demand, and regulatory evolution that together are driving transformational change in how laboratories approach nucleic acid handling. Automation is no longer a niche capability reserved for high-throughput centers; instead, it has become a strategic priority for institutions seeking to reduce variability, increase throughput, and redeploy skilled staff toward higher-value tasks. Automated workstations and integrated platforms are streamlining workflows from extraction through library preparation, enabling more consistent input material for sequencing and diagnostic assays.

Concurrently, chemistry and reagent advances are improving yield and integrity of nucleic acids extracted from challenging specimen types, extending the range of samples that can be processed reliably. Innovations in buffer formulations and enzyme engineering are driving faster protocols and greater resilience to inhibitors, which translates into improved downstream performance for both genomic and transcriptomic applications. These gains are complemented by methodological refinement in library preparation approaches, where automation-compatible kits and modular protocols are shortening turnaround time and simplifying validation.

Another significant shift is the decentralization of testing capabilities. Point-of-care and near-patient diagnostics, coupled with distributed research networks, are increasing demand for simplified, ruggedized sample preparation solutions that can operate reliably outside centralized laboratories. This trend is prompting suppliers to develop compact instruments and pre-formulated reagents that minimize user-dependent variability.

Finally, digital integration and data provenance are becoming intrinsic to sample preparation strategy. Workflow-aware software, sample tracking, and connectivity to laboratory information management systems are enhancing traceability and enabling continuous improvement. As a result, organizations are prioritizing vendors and platforms that offer not just performance but an ecosystem approach that aligns instrumentation, consumables, and software to deliver reproducible results and operational visibility.

Assessing how evolving tariff policies and trade dynamics in the United States are reshaping procurement resilience, supplier strategies, and operational continuity for sample preparation operations

Tariff policies and trade actions in the United States have amplified the need for resilient supply chains and adaptive sourcing strategies across the life sciences ecosystem. Changes in tariff structures affect the economics of procuring instruments, kits, and reagents, and they influence decisions regarding inventory strategy, vendor diversification, and localized manufacturing partnerships. For laboratories dependent on timely deliveries and validated inputs, tariff-driven cost shifts can disrupt procurement cycles and necessitate renegotiation of supplier agreements.

The cumulative impact of tariff adjustments is felt most acutely by organizations operating with lean inventory models and by small or emerging suppliers who may have limited ability to absorb added costs. In response, many buyers have sought to re-evaluate vendor contracts to incorporate price escalation clauses, extended lead times, and contingency provisions. At the same time, purchasing teams and operational leaders are exploring near-shoring and multi-sourcing arrangements to mitigate exposure to single-country production risks and customs delays.

Another consequence of tariff dynamics is accelerated interest in alternative product architectures and technologies that offer comparable performance with different supply pathways. For example, labs may consider switching between column-based extraction and magnetic separation chemistries if one route demonstrates superior availability or shorter lead times. This procurement flexibility must be balanced against validation burdens and clinical equivalence requirements, particularly in regulated diagnostic environments.

Importantly, tariff-induced cost pressures also incentivize greater collaboration between vendors and end users. Long-term supply agreements, joint inventory planning, and strategic stock buffering are becoming more common as stakeholders seek stability. These approaches, combined with an increased focus on supplier risk assessment, help laboratories maintain continuity of operations while navigating evolving trade conditions and protecting quality and compliance standards.

Deep segmentation insights revealing how instruments, kits, reagent chemistries, core technologies, varied applications, and heterogeneous end users drive differentiated procurement and validation priorities

A granular view of product segmentation clarifies where performance improvements and procurement complexity intersect. Product categories encompass instruments, kits, and reagents, with instruments including automated workstations and centrifuges that differ significantly in throughput, footprint, and integration potential. Kits cover library preparation kits and nucleic acid extraction kits, with library preparation further split into DNA and RNA library kits that have distinct enzymatic and handling requirements. Reagents span buffers and enzymes, the discrete chemistries that determine yield, integrity, and compatibility with downstream assays. Understanding these distinctions is essential for aligning procurement to workflow objectives and validation constraints.

Technological segmentation highlights the fundamental mechanisms by which nucleic acids are isolated and purified. Column-based methods remain prevalent for specific sample types due to their simplicity and familiarity, whereas magnetic separation has gained favor for automation and scalability because it is readily integrated into robotic workflows. Precipitation techniques retain utility for certain applications where cost-effectiveness and simplicity are prioritized. Each technology path brings trade-offs in terms of hands-on time, equipment compatibility, and susceptibility to inhibitors, therefore technology choice should be informed by sample type, throughput needs, and downstream analytics.

Application-based segmentation emphasizes the diversity of end-use requirements. Clinical diagnostics require stringent validation and reproducibility, with subdomains in genetic testing and infectious disease detection demanding reliable nucleic acid recovery and regulatory traceability. Forensics workflows focus on DNA fingerprinting and RNA analysis with particular attention to sample preservation and chain-of-custody, while research applications in genomics and transcriptomics often prioritize flexibility, sensitivity, and the ability to handle novel or degraded samples. These application distinctions drive different performance specifications and consumable formats.

End-user segmentation reveals divergent purchasing behaviors and validation priorities. Academic institutes, comprising research institutions and universities, typically prioritize flexibility and cost-effectiveness for exploratory work, whereas biotechnology companies-spanning biopharma firms and biotech startups-require scalable, reproducible solutions that support product development timelines. Hospitals, including clinical labs and diagnostic centers, demand validated, regulatory-compliant kits and workflows with predictable supply. Pharmaceutical companies, both major firms and generic manufacturers, emphasize consistency, batch control, and supplier reliability to support clinical trials and manufacturing processes. Recognizing these end-user characteristics allows suppliers to tailor product portfolios, support services, and validation packages to the needs of distinct customer segments.

How geographic differences across the Americas, EMEA, and Asia-Pacific determine procurement priorities, validation needs, and regional go-to-market approaches for sample preparation solutions

Regional dynamics play a decisive role in shaping supply chains, regulatory expectations, and adoption rates for sample preparation technologies. In the Americas, a concentration of advanced clinical laboratories, research institutions, and a strong biotech sector drives demand for high-throughput automation and validated kits, while procurement strategies emphasize supplier partnerships and regulatory compliance that aligns with regional agencies. The Americas also exhibits active investment in localized manufacturing and distribution networks to support rapid deployment and to manage tariff and logistics complexity.

Europe, the Middle East, and Africa present a heterogeneous landscape where regulatory harmonization across certain countries contrasts with highly localized procurement practices in others. This region demonstrates strong demand for flexible solutions that can meet diverse regulatory requirements and operate across varying laboratory infrastructures. Moreover, EMEA institutions are increasingly focused on sustainability, cold-chain optimization, and vendor transparency, which influences purchasing decisions related to consumable waste reduction and supply chain traceability.

Asia-Pacific continues to be characterized by rapid adoption of automation and a growing base of domestic manufacturers and suppliers. High-volume research initiatives, expanding clinical testing capacity, and substantial public investment in genomics and precision medicine accelerate uptake of both instruments and consumables. However, regional diversity in regulatory frameworks and specimen types necessitates tailored validation support and localized customer training programs. Collectively, these geographic distinctions underscore the importance of regionalized go-to-market strategies, flexible distribution models, and robust local technical support to ensure successful implementation and sustained usage across different territories.

Competitive landscape analysis showing how platform integration, chemistry differentiation, localized support, and strategic partnerships determine supplier strength and customer preference

Competitive dynamics within the DNA and RNA sample preparation ecosystem are defined by a mix of established instrument manufacturers, specialized reagent suppliers, and agile kit developers. Leaders in instrumentation concentrate on platform integration, automation capabilities, and software-enabled workflow management, while reagent and kit providers differentiate through chemistry innovation, ease-of-use, and validation support for specific applications such as clinical diagnostics or forensic analysis. Strategic alliances and co-development agreements between instrument and consumable vendors are increasingly common, creating bundled solutions that simplify validation and accelerate adoption.

Smaller, focused entrants often compete by offering niche chemistry advantages, lower-cost consumables, or highly specialized kits optimized for particular specimen types or downstream assays. These suppliers can be attractive partners for research institutions seeking novel performance characteristics or for organizations aiming to reduce dependency on single-source providers. At the same time, established suppliers leverage scale to provide extended service networks, regulatory documentation, and continuity assurances that are critical to clinical and pharmaceutical customers.

An additional competitive axis is the degree of support and training provided. Vendors that offer comprehensive validation kits, hands-on training, and integration assistance gain traction with customers who lack internal capacity for extensive method transfer. Furthermore, transparency in supply chain practices, quality systems, and documentation is increasingly important, as buyers weigh the operational and compliance risks associated with vendor selection. Overall, companies that can combine robust technical performance with supply reliability and strong customer support are best positioned to meet the diverse needs of contemporary laboratories.

Actionable strategic recommendations for suppliers and laboratory leaders to enhance resilience, streamline validation, and accelerate adoption of advanced sample preparation solutions

Industry leaders should prioritize strategies that enhance operational resilience, promote technological interoperability, and reduce validation friction for end users. First, investing in modular automation platforms that support multiple extraction and library preparation chemistries will enable customers to adapt workflows without wholesale hardware replacement, thereby protecting installed bases and reducing procurement barriers. Such modularity should be complemented by open interfaces and software APIs to simplify integration with laboratory information systems and analytics pipelines.

Second, suppliers and buyers alike should collaborate on validation toolkits and standardized protocols that shorten adoption timelines. Providing side-by-side performance data, ready-to-run validation packs, and thorough documentation helps clinical and research laboratories achieve equivalence faster and with lower risk. In addition, developing training programs and remote support capabilities will reduce the operational burden on customers and improve long-term satisfaction.

Third, supply chain strategies must evolve to mitigate geopolitical and tariff-related disruptions. Diversifying manufacturing footprints, establishing regional distribution buffers, and negotiating supply agreements with contingency clauses are prudent steps. Buyers should also consider multi-technology procurement approaches that permit substitution between column-based, magnetic, or precipitation methods when supply constraints or cost pressures arise, while ensuring that substitution pathways are validated for critical applications.

Finally, sustainability and lifecycle considerations are becoming business differentiators. Reducing consumable waste, optimizing reagent volumes, and offering take-back or recycling programs can lower environmental impact and appeal to customers with institutional sustainability commitments. By aligning product development, operational readiness, and customer support initiatives with these priorities, industry leaders can strengthen competitive positioning and drive long-term adoption.

A transparent and rigorously triangulated research methodology combining interviews, technical assessments, literature review, and comparative evaluation to ensure actionable and reliable insights

This analysis synthesizes primary and secondary research, technical literature, and stakeholder interviews to build an evidence-based understanding of DNA and RNA sample preparation dynamics. Primary inputs included structured interviews with laboratory directors, procurement leads, and product specialists across clinical, forensic, and research domains, supplemented by technical assessments of instrument performance and reagent robustness in representative workflows. These conversational data were complemented by careful review of peer-reviewed literature and regulatory guidance to ensure alignment with current best practices and compliance expectations.

Secondary investigation involved evaluating publicly available product specifications, vendor technical notes, and independent performance studies to triangulate claims regarding throughput, hands-on time, and compatibility across technologies. Comparative assessments prioritized reproducibility, ease of integration, and validation support as key decision criteria. Where applicable, case studies and operational anecdotes were used to illustrate practical implications of technology choices and procurement strategies.

Analytical methods emphasized cross-validation between qualitative stakeholder insights and technical documentation, with iterative refinement to identify recurring themes and pain points. Care was taken to avoid reliance on single-source assertions, and interpretive judgments were grounded in multiple corroborating inputs. The resulting methodology balances technical rigor with pragmatic relevance, ensuring that recommendations are actionable for laboratory managers, procurement officers, and strategic planners.

Concluding synthesis emphasizing the strategic importance of resilient, interoperable, and validated sample preparation practices to support reliable genomic and diagnostic outcomes

In sum, DNA and RNA sample preparation is no longer a transactional laboratory activity but a strategic domain that materially influences the quality, speed, and cost-effectiveness of downstream genomic and diagnostic workflows. Technological advances in automation and reagent chemistry have expanded capability while simultaneously raising expectations for supply continuity, validation support, and integration with digital laboratory ecosystems. As a consequence, both suppliers and end users must adopt a holistic perspective that prioritizes interoperability, traceability, and resilience.

Procurement and operational decisions should be informed by a clear understanding of product segmentation, technology trade-offs, application-specific requirements, and regional nuances. Adapting to tariff and supply-chain dynamics requires proactive planning, including diversified sourcing and collaborative supplier relationships. Ultimately, organizations that invest in modular platforms, rigorous validation toolkits, and robust supplier partnerships will be better positioned to translate sample preparation improvements into reliable diagnostic outcomes, accelerated research timelines, and sustainable operational performance.

The path forward lies in harmonizing innovation with practical implementation: enabling laboratories to harness new chemistries and automation without sacrificing compliance or continuity. By doing so, institutions can realize the full potential of nucleic acid analyses across clinical, forensic, and research applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. DNA-RNA Sample Preparation Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Automated Workstations
    • 8.1.2. Centrifuges
  • 8.2. Kits
    • 8.2.1. Library Preparation Kits
      • 8.2.1.1. Dna Library Kits
      • 8.2.1.2. Rna Library Kits
    • 8.2.2. Nucleic Acid Extraction Kits
  • 8.3. Reagents
    • 8.3.1. Buffers
    • 8.3.2. Enzymes

9. DNA-RNA Sample Preparation Market, by Technology

  • 9.1. Column Based
  • 9.2. Magnetic Separation
  • 9.3. Precipitation

10. DNA-RNA Sample Preparation Market, by Application

  • 10.1. Clinical Diagnostics
    • 10.1.1. Genetic Testing
    • 10.1.2. Infectious Diseases
  • 10.2. Forensics
    • 10.2.1. Dna Fingerprinting
    • 10.2.2. Rna Analysis
  • 10.3. Research
    • 10.3.1. Genomics
    • 10.3.2. Transcriptomics

11. DNA-RNA Sample Preparation Market, by End User

  • 11.1. Academic Institutes
    • 11.1.1. Research Institutions
    • 11.1.2. Universities
  • 11.2. Biotechnology Companies
    • 11.2.1. Biopharma Firms
    • 11.2.2. Biotech Startups
  • 11.3. Hospitals
    • 11.3.1. Clinical Labs
    • 11.3.2. Diagnostic Centers
  • 11.4. Pharmaceutical Companies
    • 11.4.1. Big Pharma
    • 11.4.2. Generic Pharma

12. DNA-RNA Sample Preparation Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. DNA-RNA Sample Preparation Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. DNA-RNA Sample Preparation Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States DNA-RNA Sample Preparation Market

16. China DNA-RNA Sample Preparation Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. Akonni Biosystems, Inc.
  • 17.7. Bio-Rad Laboratories, Inc.
  • 17.8. bioMerieux S.A.
  • 17.9. Danaher Corporation
  • 17.10. F. Hoffmann-La Roche Ltd
  • 17.11. Illumina, Inc.
  • 17.12. Merck KGaA
  • 17.13. New England Biolabs, Inc.
  • 17.14. Norgen Biotek Corp.
  • 17.15. Omega Bio-tek, Inc.
  • 17.16. PerkinElmer, Inc.
  • 17.17. Promega Corporation
  • 17.18. QIAGEN N.V.
  • 17.19. Sage Science, Inc.
  • 17.20. Takara Bio Inc.
  • 17.21. Tecan Group Ltd.
  • 17.22. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 268. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 271. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 272. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 273. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 274. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 277. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 278. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 279. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 281. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 282. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS DNA-RNA SAMPLE PREPARATION MAR